Efficacy Regarding Renal Function of Everolimus in Combination With Specific Standard Immunosuppressive Regimen Lung Transplant Recipients
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Everolimus
Related studies linked through entity extraction aliases.
Irinotecan, Cetuximab and Everolimus to Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy of RAD001 + TACE in Localized Unresectable HCC
- Status
- TERMINATED
- Phase
- PHASE2
Efficacy of Everolimus Alone or in Combination With Pasireotide LAR in Advanced PNET
- Status
- TERMINATED
- Phase
- PHASE2
Efficacy and Safety of Induction Strategies Combined With Low Tacrolimus Exposure in Kidney Transplant Recipients Receiving Everolimus or Sodium Mycophenolate
- Status
- COMPLETED
- Phase
- PHASE4
89Zr-bevacizumab PET Imaging in Patients With Neuroendocrine Tumors
- Status
- COMPLETED
- Phase
- N/A
Everolimus, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Untreated Diffuse Large B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Everolimus, Erlotinib Hydrochloride, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer Previously Treated With Radiation Therapy
- Status
- WITHDRAWN
- Phase
- PHASE1
Pasireotide (SOM230) With or Without Everolimus in Treating Patients With Hormone Resistant, Chemotherapy Naive Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Everolimus and Docetaxel in Treating Patients With Recurrent, Locally Advanced, or Metastatic Head and Neck Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study Of Everolimus, Trastuzumab And Vinorelbine In HER2-Positive Breast Cancer Brain Metastases
- Status
- COMPLETED
- Phase
- PHASE2
Tamoxifen-RAD001 Versus Tamoxifen Alone in Patients With Anti-aromatase Resistant Breast Metastatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Everolimus in Combination With Imatinib Mesylate in Treating Patients With Locally Advanced, Locally Recurrent, or Metastatic Soft Tissue Sarcoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Carboplatin, PLD and Everolimus in Certain Gynecologic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Comparison of Immunosuppression on Progression of Arteriosclerosis in Renal Transplantation
- Status
- TERMINATED
- Phase
- PHASE4
Pasireotide & Everolimus in Adult Patients With Radioiodine-Refractory Differentiated & Medullary Thyroid Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Immediate Conversion From Tacrolimus to Everolimus in Stable Maintenance Renal Transplant Recipients
- Status
- WITHDRAWN
- Phase
- PHASE4
Open Label, Single Arm Trial to Characterize Patients With Metastatic RCC Treated With Everolimus After Failure of the First VEGF-targeted Therapy (MARC-2)
- Status
- COMPLETED
- Phase
- PHASE4
SCHEDULE - Scandinavian Heart Transplant Everolimus de Novo Study With Early Calcineurin Inhibitor (CNI) Avoidance
- Status
- COMPLETED
- Phase
- PHASE4
Study of Everolimus and Sorafenib in Patients With Advanced Thyroid Cancer Who Progressed on Sorafenib Alone
- Status
- UNKNOWN
- Phase
- PHASE2